24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Molecular and biochemical basis <strong>of</strong> disease<br />

P05.018<br />

screening for cADAsiL in central italian patients<br />

L. Pianese 1 , A. Cappelli 1,2 , M. Scarcella 3 , G. Cacchiò 3 , P. Staffolani 1 , M.<br />

Ragno 3 ;<br />

1 Laboratorio Medicina Molecolare, ASUR ZT13, Ascoli Piceno, Italy, 2 School <strong>of</strong><br />

Advanced Studies: Environmental Sciences and Public Health, Camerino, Italy,<br />

3 U. O. Neurologia, ASUR ZT13, Ascoli Piceno, Italy.<br />

Cerebral autosomal dominant arteriopathy with subcortical infarcts and<br />

leukoencephalopathy (CADASIL) is an inherited autosomal dominant<br />

condition characterized by a variable combination <strong>of</strong> recurrent cerebral<br />

ischemic episodes, cognitive deficits, migraine with aura and psychiatric<br />

symptoms . It results from mutations distributed throughout the<br />

34 EGFRs (epidermal growth factor-like repeats) <strong>of</strong> the Notch3 gene,<br />

leading to the addition or the loss <strong>of</strong> a cysteine residue .<br />

We performed genetic testing for Notch3 mutations in 45 probands<br />

<strong>of</strong> different family with suspected CADASIL who had been referred to<br />

our service in 2007 . DNA samples were analyzed for mutations in all<br />

exons <strong>of</strong> EGFRs using an appropriate screening protocol considering<br />

the mutations distribution in exons gene .<br />

The sequence analysis <strong>of</strong> Notch3 gene revealed the presence <strong>of</strong> three<br />

previously reported missense mutations: C144F in exon 4, G528C in<br />

exon 10 and R1006C in exon 19 . In particular, the mutation C144F was<br />

found in one family, whereas the mutations G528C and R1006C were<br />

found in two and seven families respectively, with the same regional<br />

origin . These results suggest a higher frequency <strong>of</strong> exon 10 and 19<br />

mutations in central Italy and confirm that the genetic procedures could<br />

be optimized by a geographical region-oriented genetic analysis .<br />

We are extending genetic analysis to the remaining exons <strong>of</strong> Notch3<br />

gene in patients with clinical and strumental features more suggestive<br />

<strong>of</strong> CADASIL phenotype, negative for EGFRs mutations .<br />

P05.019<br />

KRIT1 gene mutations in Sardinian patients with cerebral<br />

cavernous malformations<br />

M. A. Melis1 , M. Addis1 , R. Congiu1 , C. Meloni1 , A. Loi2 , M. Melis3 , M. Loi3 , M.<br />

Cau1 ;<br />

1 2 University <strong>of</strong> Cagliari, Cagliari, Italy, Ospedale Regionale per le Microcitemie,<br />

Cagliari, Italy, 3Azienda Ospedaliera Brotzu, Cagliari, Italy.<br />

Cerebral Cavernous Malformations (CCM) are CNS vascular anomalies<br />

associated with seizures, headaches and hemorrhagic strokes and<br />

represents 10 to 20 percent <strong>of</strong> cerebral lesions . CCM is present in 0 .1<br />

to 0 .5 <strong>of</strong> the population . This disorder most <strong>of</strong>ten occurs sporadically<br />

but may also be familial . Familial cases are inherited as a dominant<br />

trait with incomplete penetrance and are estimated to account for 10-<br />

40 % <strong>of</strong> the patients. The identification <strong>of</strong> the genes involved in such<br />

disorders allow to characterize carriers <strong>of</strong> the mutations without clear<br />

symptoms. The first gene involved in CCM1 is KRIT 1. In addition to<br />

KRIT1 two other genes have been described: MGC4607 (CCM2) and<br />

PDCD10 (CCM3) . We selected 14 patients belonging to seven Sardinian<br />

families on the basis <strong>of</strong> clinical symptoms and Magnetic Resonance<br />

results . MLPA analysis <strong>of</strong> KRIT1, MGC4607 and PDCD10 gave<br />

negative results . Sequencing analysis <strong>of</strong> KRIT1 gene was performed<br />

in all the patients. We identified a 4bp deletion in exon 9 leading to a<br />

premature stop codon in a patient with clear phenotype . The same mutation<br />

has been found in three relatives showing very mild symptoms .<br />

In 5 subjects belonging to four unrelated families a unique nonsense<br />

mutation (C329X) has been found . Haplotype analysis in these four<br />

families revealed a common origin <strong>of</strong> the mutation . These data suggest<br />

a “founder effect”, already described in different populations .<br />

P05.020<br />

Functional analysis <strong>of</strong> cD96, a causative gene for a form <strong>of</strong> c<br />

(Opitz trigonocephaly) syndrome<br />

T. Kaname 1,2 , K. Yanagi 1 , Y. Chinen 1 , Y. Makita 3 , N. Okamoto 4 , K. Kurosawa 5 ,<br />

H. Maehara 1 , Y. Fukushima 6 , A. Bohring 7 , J. M. Opitz 8 , K. Yoshiura 9,2 , N. Niikawa<br />

10,2 , K. Naritomi 1,2 ;<br />

1 University <strong>of</strong> the Ryukyus, Nishihara-cho, Japan, 2 SORST, JST, Kawaguchi,<br />

Japan, 3 Asahikawa Medical College, Asahikawa, Japan, 4 Osaka Medical Center<br />

and Research Institute for Maternal and Child Health, Izumi, Japan, 5 Kanagawa<br />

Children’s Medical Center, Yokohama, Japan, 6 Shinshu University School <strong>of</strong><br />

Medicine, Matsumoto, Japan, 7 Westfälische Wilhelms-Universität, Münster,<br />

Germany, 8 University <strong>of</strong> Utah School <strong>of</strong> Medicine, Salt Lake City, UT, United<br />

States, 9 Nagasaki University Graduate School <strong>of</strong> Biomedical Sciences, Na-<br />

gasaki, Japan, 10 Health Sciences University <strong>of</strong> Hokkaido, Tobetsu-cho, Japan.<br />

The C syndrome is characterized by trigonocephaly associated with<br />

unusual facies, psychomotor retardation, redundant skin, joint and<br />

limb abnormalities, and visceral anomalies . In an individual with<br />

the C syndrome harboring a balanced chromosomal translocation,<br />

t(3;18)(q13.13;q12.1), we identified a gene (CD96), which encodes<br />

a member <strong>of</strong> the immunoglobulin superfamily, was disrupted at the<br />

3q13 .3 breakpoint . In mutation analysis <strong>of</strong> karyotypically normal patients<br />

with the C or C-like syndromes, we identified a missense mutation<br />

in exon 6 <strong>of</strong> the CD96 gene in one patient and found reduced expression<br />

in two patients . In order to know the function <strong>of</strong> CD96, we established<br />

normal CD96 or the mutated CD96 expressed cell lines and<br />

investigated their characters especially on cell-adhesion activity and<br />

cell-growth activity . Cells with the normal CD96 protein increased both<br />

the cell-adhesion and growth activities compared with MOCK cells . On<br />

the other hand, cells with the mutated CD96 protein lost the activities in<br />

vitro. These findings may indicate that CD96 mutations cause a form <strong>of</strong><br />

the C syndrome by interfering with cell adhesion and growth .<br />

P05.021<br />

Evidence on microRNA-mediated regulation <strong>of</strong> CDK5R1 gene<br />

expression<br />

S. Moncini 1 , M. Venturin 1 , A. Salvi 2 , V. Lanzi 1 , C. Sabelli 2 , G. De Petro 2 , S.<br />

Barlati 2 , P. Riva 1 ;<br />

1 University <strong>of</strong> Milan, Milan, Italy, 2 University <strong>of</strong> Brescia, Brescia, Italy.<br />

CDK5R1 encodes for p35, an activator <strong>of</strong> CDK5, which is involved<br />

in neuronal migration and differentiation during central nervous system<br />

development and has been candidated for mental retardation .<br />

We recently reported that the large 3’ untranslated region (3’UTR) <strong>of</strong><br />

CDK5R1 contains regulatory elements affecting transcript stability .<br />

Besides several AREs, many microRNAs (miRNAs) target sites have<br />

been predicted by PicTar s<strong>of</strong>tware . We evaluated the expression <strong>of</strong><br />

nine pre-miRNAs, among the 20 miRNAs predicted to bind CDK5R1,<br />

in six cell lines, including two neuroblastoma derived lines . Among the<br />

expressed miRNAs, we observed that miR-15a, miR-103 and miR-<br />

107 presented a high number <strong>of</strong> target sites with a free energy

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!